Inventor · disambiguated record
Yutaka Kanda
Also filed as: KANDA YUTAKA
65 granted patents·15 pending applications·2,487 citations·filing 1988–2019
99Inventor score
Top patents by PatentIndex Score
80 records- 0199US7214775B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KOGYO KK·Filed 2005·Granted May 8, 2007·363 cites·7 claims
- 0298US7737325B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 15, 2010·55 cites·14 claims
- 0398US7708992B2Methods for producing antibody compositions with increased ADCCKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted May 4, 2010·51 cites·16 claims
- 0498US7651688B2Method of modulating the activity of functional immune molecules to CD52KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jan 26, 2010·47 cites·3 claims
- 0598US7425446B2Antibody composition-producing cellKYOWA HAKKO KOGYO KK·Filed 2005·Granted Sep 16, 2008·93 cites·6 claims
- 0698US7393683B2Mammalian host cell modified by RNAi to inhibit α 1,6-fucosyltransferaseKYOWA HAKKO KOGYO KK·Filed 2005·Granted Jul 1, 2008·63 cites·6 claims
- 0798US6946292B2Cells producing antibody compositions with increased antibody dependent cytotoxic activityKYOWA HAKKO KOGYO KK·Filed 2001·Granted Sep 20, 2005·566 cites·12 claims
- 0898US5084468ADc-88a derivativesKYOWA HAKKO KOGYO KK·Filed 1989·Granted Jan 28, 1992·156 cites·10 claims
- 0997US8067232B2Antibody composition-producing cell with inactivated A-1,6-fusocyltransferaseKANDA YUTAKA·Filed 2008·Granted Nov 29, 2011·45 cites·5 claims
- 1097US7846725B2Antibody composition-producing cell in which enzyme expression is inhibited by RNAiKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Dec 7, 2010·35 cites·6 claims
- 1197US7741442B2Antibody composition exhibiting increased cellular cytotoxicity due to glycosylationKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Jun 22, 2010·32 cites·4 claims
- 1297US7718175B2Method of modulating the activity of functional immune molecules to interleukin-5 receptor proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 18, 2010·32 cites·3 claims
- 1397US7687061B2Method of modulating the activity of functional immune molecules to Her-2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 30, 2010·29 cites·3 claims
- 1497US7682610B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·33 cites·3 claims
- 1597US5187186APyrroloindole derivativesKYOWA HAKKO KOGYO KK·Filed 1991·Granted Feb 16, 1993·189 cites·5 claims
- 1697US5070092APyrroloindole derivatives related to dc-88a compoundKYOWA HAKKO KOGYO KK·Filed 1990·Granted Dec 3, 1991·196 cites·9 claims
- 1796US7763246B2Method of modulating the activity of functional immune molecules to platelet-derived growth factor receptorKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Jul 27, 2010·23 cites·3 claims
- 1896US7708997B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted May 4, 2010·24 cites·3 claims
- 1996US7682611B2Method of modulating the activity of functional immune molecules to CXCR4 proteinKYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Mar 23, 2010·26 cites·3 claims
- 2096US7655228B2Method of modulating the activity of functional immune molecules to GM2KYOWA HAKKO KIRIN CO LTD·Filed 2007·Granted Feb 2, 2010·24 cites·3 claims
- 2195US6518268B1Telomerase inhibitors and methods of their useGERON CORP·Filed 2000·Granted Feb 11, 2003·59 cites·33 claims
- 2294US7749753B2Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lostKYOWA HAKKO KIRIN CO LTD·Filed 2003·Granted Jul 6, 2010·53 cites·11 claims
- 2392US9023999B2Anti-CD27 antibodyMORI KATSUHIRO·Filed 2009·Granted May 5, 2015·32 cites·24 claims
- 2492US8039595B2Glycoengineered, recombinant antibody to CCR-4 with reduced fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Oct 18, 2011·9 cites·5 claims
- 2591US7691810B2Method of producing recombinant antithrombin III compositionKYOWA HAKKO KIRIN CO LTD·Filed 2004·Granted Apr 6, 2010·26 cites·3 claims
- 2691US5117006ADc-88a derivatives useful as antitumor agentsKYOWA HAKKO KOGYO KK·Filed 1991·Granted May 26, 1992·43 cites·3 claims
- 2790US8679491B2Method of modulating the activity of functional immune moleculesHANAI NOBUO·Filed 2009·Granted Mar 25, 2014·12 cites·2 claims
- 2889US8101185B2Anti-il-5 antibody composition exhibiting cellular cytotoxicity due to glycosylationKANDA YUTAKA·Filed 2010·Granted Jan 24, 2012·6 cites·4 claims
- 2987US8895266B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2012·Granted Nov 25, 2014·4 cites·4 claims
- 3087US8158760B2Glycoengineered, recombinant antibodyKANDA YUTAKA·Filed 2009·Granted Apr 17, 2012·4 cites·4 claims
- 3186US8329443B2Antibody composition-producing cellKANDA YUTAKA·Filed 2011·Granted Dec 11, 2012·4 cites·4 claims
- 3286US8110195B2Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibodyKANDA YUTAKA·Filed 2010·Granted Feb 7, 2012·4 cites·4 claims
- 3383US10233247B2Method of modulating the activity of functional immune moleculesKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Mar 19, 2019·2 cites·6 claims
- 3481US8501914B2Recombinant protein S compositionKANDA YUTAKA·Filed 2009·Granted Aug 6, 2013·4 cites·14 claims
- 3581US5733924ADC 107 derivatives and treatment methodsKYOWA HAKKO KOGYO KK·Filed 1996·Granted Mar 31, 1998·32 cites·14 claims
- 3680US5925641AFarnesyltransferase inhibitorKYOWA HAKKO KOGYO KK·Filed 1997·Granted Jul 20, 1999·24 cites·5 claims
- 3779US7470717B2Indazole derivativesKYOWA HAKKO KOGYO KK·Filed 2004·Granted Dec 30, 2008·14 cites·15 claims
- 3877US7538224B2Hsp90 family protein inhibitorsKYOWA HAKKO KOGYO KK·Filed 2004·Granted May 26, 2009·8 cites·12 claims
- 3976US7776849B2Benzenoid ansamycin derivativeKYOWA HAKKO KIRIN CO LTD·Filed 2006·Granted Aug 17, 2010·3 cites·20 claims
- 4076US6548536B2Agent for inducing apoptosisKYOWA HAKKO KOGYO KK·Filed 2001·Granted Apr 15, 2003·13 cites·16 claims
- 4174US7605272B2IGF-1R inhibitorKYOWA HAKKO KIRIN CO LTD·Filed 2006·Granted Oct 20, 2009·3 cites·16 claims
- 4274US2019360015A1Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 4374US2010143388A1Antibody Composition-Producing CellKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 4474US2020017593A1Method of producing antibodies with n-glycoside-linked sugar chains lacking fucosylationKYOWA HAKKO KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 4573US8367407B2Cells with altered fucosylation and producing antibodies therefromKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Feb 5, 2013·0 cites·14 claims
- 4672US9409982B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Aug 9, 2016·0 cites·7 claims
- 4770US7767693B2Hsp90 family protein inhibitorsKYOWA HAKKO KIRIN CO LTD·Filed 2009·Granted Aug 3, 2010·0 cites·8 claims
- 4869US9115759B2Roller bearingKANDA YUTAKA·Filed 2012·Granted Aug 25, 2015·2 cites·6 claims
- 4968US10233475B2Antibody composition-producing cellKYOWA HAKKO KIRIN CO LTD·Filed 2016·Granted Mar 19, 2019·0 cites·20 claims
- 5068US7538241B2Hsp90 family protein inhibitorsKYOWA HAKKO KOGYO KK·Filed 2004·Granted May 26, 2009·5 cites·20 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yutaka Kanda files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →